These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33837785)

  • 21. Development of genetic maps of non-conventional yeasts.
    Ogrydziak DM
    J Basic Microbiol; 1988; 28(3):185-96. PubMed ID: 3057173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yeasts in nanotechnology-enabled oral vaccine and gene delivery.
    Ivanova E
    Bioengineered; 2021 Dec; 12(1):8325-8335. PubMed ID: 34592900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug delivery issues in vaccine development.
    Powell MF
    Pharm Res; 1996 Dec; 13(12):1777-85. PubMed ID: 8987071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of different vaccine delivery systems for cancer therapy.
    Bolhassani A; Safaiyan S; Rafati S
    Mol Cancer; 2011 Jan; 10():3. PubMed ID: 21211062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid (DNA) immunization as a platform for dengue vaccine development.
    Porter KR; Raviprakash K
    Vaccine; 2015 Dec; 33(50):7135-40. PubMed ID: 26458805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.
    King TH; Shanley CA; Guo Z; Bellgrau D; Rodell T; Furney S; Henao-Tamayo M; Orme IM
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
    Karch CP; Burkhard P
    Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The application of nucleic acid vaccines in veterinary medicine.
    Dunham SP
    Res Vet Sci; 2002 Aug; 73(1):9-16. PubMed ID: 12208102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and production of recombinant subunit vaccines.
    Hansson M; Nygren PA; Ståhl S
    Biotechnol Appl Biochem; 2000 Oct; 32(2):95-107. PubMed ID: 11001870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immuno-enhancement of Taishan Pinus massoniana pollen polysaccharides on recombinant Bordetella avium ompA expressed in Pichia pastoris.
    Liu L; Yu C; Wang C; Shao M; Yan Z; Jiang X; Chi S; Wang Z; Wei K; Zhu R
    Microb Pathog; 2016 Jun; 95():54-61. PubMed ID: 26975477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactic Acid Bacteria as Delivery Vehicle for Therapeutics Applications.
    Batista VL; da Silva TF; de Jesus LCL; Tapia-Costa AP; Drumond MM; Azevedo V; Mancha-Agresti P
    Methods Mol Biol; 2021; 2183():447-459. PubMed ID: 32959259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
    Bagley KC; Schwartz JA; Andersen H; Eldridge JH; Xu R; Ota-Setlik A; Geltz JJ; Halford WP; Fouts TR
    Viral Immunol; 2017 Apr; 30(3):178-195. PubMed ID: 28085634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A perspective on the use of Pleurotus for the development of convenient fungi-made oral subunit vaccines.
    Pérez-Martínez AS; Acevedo-Padilla SA; Bibbins-Martínez M; Galván-Alonso J; Rosales-Mendoza S
    Vaccine; 2015 Jan; 33(1):25-33. PubMed ID: 25444808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyvalent recombinant antigens: a new vaccine strategy.
    Kingsman SM; Kingsman AJ
    Vaccine; 1988 Aug; 6(4):304-6. PubMed ID: 2847436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat treatment improves antigen-specific T cell activation after protein delivery by several but not all yeast genera.
    Bazan SB; Breinig T; Schmitt MJ; Breinig F
    Vaccine; 2014 May; 32(22):2591-8. PubMed ID: 24674665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.